Trial Profile
A single-center randomized double-blind placebo-controlled trial "Treatment of Systemic Sclerosis with Rituximab: evaluation of the effectiveness of B-cell depletion therapy"
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2015 Interim results (n=6, after one treatment course) published in the Clinical and Experimental Rheumatology.
- 24 Aug 2015 New trial record